Search results for: Adrian Towse
Filter search results
Bengt Jönsson Honoured for Contribution to Health Economics
6 August 2014
…The chapter contributed by OHE’s Adrian Towse[2] discusses Bengt’s observations in a 2011 publication[3] about the role of relative effectiveness research (RE) in the European medicines market. To ensure value…
Value and Cancer: Journal of Cancer Policy Special Issue
25 January 2017
…the value of a prevented fatality. The third article, authored by Professors Adrian Towse and Lou Garrison, focuses on precision cancer medicine. Lou Garrison was recently appointed as an OHE Senior…
How Much Should Society Pay for a New Orphan Drug? A Contribution to this Debate is now Available in a New OHE Research Paper
18 July 2018
…prices in many countries. The question then arises as to what should be a reasonable price for an orphan drug? The research by OHE authors Mikel Berdud and Adrian…
Time to Tackle the Challenges around Combination Therapies for Cancer
29 March 2021
…world. A report of the workshop was published in May 2020. The authors, Nick Latimer, University of Sheffield, and OHE’s Adrian Towse and Chris Henshall, explain that the problem arises…
OHE Annual Lecture Webinar 2020: How Should the World Pay for a COVID-19 Vaccine?
24 June 2020, 11:00pm
In place of OHE’s 2020 Annual Lecture, Adrian Towse will give a webinar-lecture on June 25th at 2 pm (BST) on payment models for a COVID-19 vaccine. He will discuss…
ISPOR Europe Round-up: “Gene Therapies: Where High Promise Meets High Uncertainty, How Should HTA Methodologies Appropriately Value and Enable Access?”
8 December 2022
In November, ISPOR Europe was hosted in person for the first time since 2019 at the Austria Centre, Vienna. In front of a full theatre, OHE’s Professor Adrian Towse introduced…
News Release: Fighting Superbugs
6 July 2011
…by a grant from GlaxoSmithKline. It is available for download from the OHE website. Professor Adrian Towse, Director +44 207 747 1407 Priya Sharma, Health Economist +44 207 747 8860…
OHE Models Incentives for Antibiotic Drug Development
18 March 2014
…new model aimed at encouraging the development of new antibiotics was presented recently by OHE’s Chris Hoyle, who collaborated with Adrian Towse and Jorge Mestre-Ferrandiz in designing the model. A…
Spotlight on OHE: Adaptive Pathways, Economic Evaluation, Stated Preferences and Life-cycle Price Modelling
5 November 2014
…new regulatory approaches to accelerating medicines availability, and suggest recommendations on how best to ensure success of new Facilitated Regulatory Pathways. OHE’s Adrian Towse presented an academic perspective, arguing…